National Cancer Institute, France   Report issue

Founded: Paris France (2005)

Organization Overview

First Clinical Trial
2005
NCT00421317
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

French National Cancer Institute | National Cancer Institute, France